Chinese Academy of Medical Sciences, Fuwai Hospital
fuwaihospital.orgLive pipeline data from ClinicalTrials.gov, refreshed daily.
Total trials
143
Active
43
Phase 3
4
Total enrollment
1,306,125
Pipeline matrix
Showing 13 of 13 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| colchicine | — | — | — | — | — | 2 | |
| Experimental: Rivaroxaban monotherapy | — | — | — | — | — | 1 | |
| Active Comparator: Rivaroxaban+Clopidogrel | — | — | — | — | — | 1 | |
| Experimental: Aspirin monotherapy | — | — | — | — | — | 1 | |
| Active Comparator: Aspirin+Clopidogrel | — | — | — | — | — | 1 | |
| FMT | — | — | — | — | 3 | ||
| remimazolam besylate | — | — | — | — | — | 1 | |
| propofol | — | — | — | — | — | 1 | |
| RASI and/or a single pill combination based RASI | — | — | — | — | — | 1 | |
| Spironolactone | — | — | — | — | — | 1 | |
| Randomized to optimal medical therapy | — | — | — | — | — | 1 | |
| Intensive lipid-lowering control | — | — | — | — | — | 1 | |
| Moderate-intensity lipid-lowering control | — | — | — | — | — | 1 |
Next readouts
- 2025-05
- 2025-12-31
- 2026-12-31
- 2026-12-31
- 2027-03-31
- 2027-05-31
- 2027-10-31
- 2028-09-30
- 2029-06
Top conditions
- Coronary Artery Disease13
- Hypertension8
- COPD8
- Coronary Heart Disease6
- Heart Failure6
- Hyperaldosteronism5
- Migraine4
- Atrial Fibrillation4
Frequently asked questions about Chinese Academy of Medical Sciences, Fuwai Hospital
- How many clinical trials does Chinese Academy of Medical Sciences, Fuwai Hospital have on ClinicalTrials.gov?
- Chinese Academy of Medical Sciences, Fuwai Hospital is listed as the lead sponsor on 143 clinical trials in ClinicalTrials.gov, 43 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Chinese Academy of Medical Sciences, Fuwai Hospital's trials are in Phase 3?
- 4 of Chinese Academy of Medical Sciences, Fuwai Hospital's trials are in Phase 3, spread across 13 active drug programs.
- What therapeutic areas does Chinese Academy of Medical Sciences, Fuwai Hospital focus on?
- Chinese Academy of Medical Sciences, Fuwai Hospital's most-studied conditions on ClinicalTrials.gov are Coronary Artery Disease, Hypertension, COPD, Coronary Heart Disease, Heart Failure.
- When are Chinese Academy of Medical Sciences, Fuwai Hospital's next clinical trial readouts?
- Chinese Academy of Medical Sciences, Fuwai Hospital has 9 upcoming primary-completion readouts tracked here; the soonest is “The Efficacy and Safety of Remimazolam Besylate for Cardiac Anesthesia”, expected around 2025-05.